Rodrigues Daniela A, Herdeiro Maria Teresa, Mateos-Campos Ramona, Figueiras Adolfo, Roque Fátima
Biotechnology Research, Innovation and Design for Health Products (BRIDGES) - Research Laboratory on Epidemiology and Population Health, Polytechnic of Guarda (IPG), Guarda, Portugal.
Health Sciences Research Centre, University of Beira Interior (CICS-UBI), Covilhã, Portugal.
Expert Opin Drug Saf. 2025 Jul;24(7):831-837. doi: 10.1080/14740338.2024.2385479. Epub 2024 Aug 6.
Considering the vulnerability of older adults to adverse drug reactions, medications with strong anticholinergic properties are considered potentially inappropriate for this population. This study aims to characterize older adults' profile of anticholinergics use and to identify the factors associated with their potentially inappropriate use.
A retrospective study was conducted on 1200 older adults in primary health care centers of Portugal between April 2021 and August 2022. Potentially inappropriate use was assessed according to the 2023 Beers criteria. Logistic regression analyses were performed to determine associations between independent variables and potentially inappropriate use.
A 8.9% (95% CI 0.074-0.107) of the older adults were exposed to one or more potentially inappropriate anticholinergics, and amitriptyline was the most used (2.0%). Multivariate analysis revealed that use was associated with a higher mean number of medications (OR 1.173, 95% CI 1.115-1.234), diagnoses of depression (OR 2.889, 95% CI 1.785-4.674) and psychiatric disorders (OR 1.654, 95% CI 1.003-2.729).
This study underscores the importance of vigilance in prescribing anticholinergic medications to older adults, particularly those with higher medication burdens and mental health diagnoses. By identifying factors associated with potentially inappropriate use, healthcare providers can better tailor medication regimens to mitigate risks and optimize the well-being of older adults.
考虑到老年人易发生药物不良反应,具有强效抗胆碱能特性的药物被认为对该人群可能不合适。本研究旨在描述老年人使用抗胆碱能药物的情况,并确定与其潜在不适当使用相关的因素。
2021年4月至2022年8月期间,对葡萄牙初级卫生保健中心的1200名老年人进行了一项回顾性研究。根据2023年《比尔斯标准》评估潜在不适当使用情况。进行逻辑回归分析以确定自变量与潜在不适当使用之间的关联。
8.9%(95%置信区间0.074 - 0.107)的老年人使用了一种或多种潜在不适当的抗胆碱能药物,其中阿米替林使用最为频繁(2.0%)。多变量分析显示,使用与更高的平均用药数量(比值比1.173,95%置信区间1.115 - 1.234)、抑郁症诊断(比值比2.889,95%置信区间1.785 - 4.674)和精神疾病诊断(比值比1.654,95%置信区间1.003 - 2.729)相关。
本研究强调了在为老年人开具抗胆碱能药物时保持警惕的重要性,特别是对于那些用药负担较重和有心理健康诊断的老年人。通过识别与潜在不适当使用相关的因素,医疗保健提供者可以更好地调整用药方案,以降低风险并优化老年人的健康状况。